Publications

Journals

• Mendez MA; Horder J; Myers J; Coghlan S; Stokes P; Erritzoe D; Howes O; Lingford-Hughes A; et alMurphy D; Nutt D. (21 Apr 2012). The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology. DOI.
• Colasanti A; Searle GE; Long CJ; Hill SP; Reiley RR; Quelch D; Erritzoe D; Tziortzi AC; et alReed LJ; Lingford-Hughes AR; Waldman AD; Schruers KR; Matthews PM; Gunn RN; Nutt DJ; Rabiner EA. (2 Mar 2012). Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration. Biol Psychiatry. DOI.
• Thomson AD; Guerrini I; Bell D; Drummond C; Duka T; Field M; Kopelman M; Lingford-Hughes A; et alSmith I; Wilson K; Marshall EJ. (Mar 2012). Alcohol-related brain damage: report from a medical council on alcohol symposium, June 2010. Alcohol Alcohol. 47:84-91. DOI.
• Lees R; Kingston R; Williams TM; Henderson G; Lingford-Hughes A; Hickman M. (May 2012). Comparison of ethyl glucuronide in hair with self-reported alcohol consumption. Alcohol Alcohol. 47:267-272. DOI.
• Nutt DJ; Lingford-Hughes A; Chick J. (Feb 2012). Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?. J Psychopharmacol. 26:199-204. DOI.
• Myers JF; Rosso L; Watson BJ; Wilson SJ; Kalk NJ; Clementi N; Brooks DJ; Nutt DJ; et alTurkheimer FE; Lingford-Hughes AR. (Apr 2012). Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images. J Cereb Blood Flow Metab. 32:731-744. DOI.
• Morrow AL; Montpied P; Lingford-Hughes A; Paul SM. (May 1990). Chronic ethanol and pentobarbital administration in the rat: effects on GABAA receptor function and expression in brain. Alcohol. 7:237-244.
• Busatto GF; Pilowsky LS; Costa DC; Ell PJ; Lingford-Hughes A; Kerwin RW. (Jan 1995). In vivo imaging of GABAA receptors using sequential whole-volume iodine-123 iomazenil single-photon emission tomography. Eur J Nucl Med. 22:12-16.
• Lingford-Hughes A; Marshall J. (Jun 1998). New drug treatments for alcohol problems. Response to Moncrieff & Drummond. Addiction. 93:925-927.
• Busatto GF; Pilowsky LS; Costa DC; Mertens J; Terriere D; Ell PJ; Mulligan R; Travis MJ; et alLeysen JE; Lui D; Gacinovic S; Waddington W; Lingford-Hughes A; Kerwin RW. (Feb 1997). Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. Eur J Nucl Med. 24:119-124.
• Lingford-Hughes A. (Apr 1996). Characterisation of the effects of alcohol use and abuse on the brain. J R Soc Health. 116:122-123.
• Lingford-Hughes A; Marshall J. (1 Jun 1998). Response to Moncrieff & Drummond. ADDICTION. 93:925-926. Author weblink.
• Lingford-Hughes AR; Acton PD; Gacinovic S; Suckling J; Busatto GF; Pilowsky LS; Costa DC; Bullmore E; et alWoodruff P; Boddington S; Ell PJ; Marshall EJ; Kerwin RW. (1 May 1998). Gender differences in the pattern of reduced levels of the GABA benzodiazepine receptor in alcohol dependency - An L23 I-iomazenil SPECT and MRI study. JOURNAL OF NUCLEAR MEDICINE. 39:204P-204P. Author weblink.
• Lingford-Hughes AR; Acton PD; Gacinovic S; Suckling J; Busatto GF; Boddington SJA; Bullmore E; Woodruff PW; et alCosta DC; Pilowsky LS; Ell PJ; Marshall EJ; Kerwin RW. (1 Aug 1998). Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. BRITISH JOURNAL OF PSYCHIATRY. 173:116-122. Author weblink DOI.
• Weinstein A; Lingford-Hughes A; Martinez-Raga J; Marshall J. (1 Sep 1998). What makes alcohol-dependent individuals early in abstinence crave for alcohol: Exposure to the drink, images of drinking, or remembrance of drinks past?. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 22:1376-1381. Author weblink DOI.
• Suckling J; Brammer MJ; Lingford-Hughes A; Bullmore ET. (1 Feb 1999). Removal of extracerebral tissues in dual-echo magnetic resonance images via linear scale-space features. MAGNETIC RESONANCE IMAGING. 17:247-256. Author weblink DOI.
• Lingford-Hughes A. (1 Oct 2002). Imaging GABAA receptor subtypes with PET. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S136-S137. Author weblink.
• Lingford-Hughes AR. (1 Dec 2005). Drugs for relapse prevention of alcoholism. ADDICTION. 100:1889-1889. Author weblink DOI.
• Kalk N; Rabiner EA; Lingford-Hughes AR. (1 Sep 2011). IMAGING NEUROINFLAMMATION IN ALCOHOLISM. ALCOHOL AND ALCOHOLISM. 46:13-13. Author weblink.
• Lingford-Hughes A. (Sep 2002). There is more to dopamine than just pleasure. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'. Behav Pharmacol. 13:367-370.
• Lingford-Hughes A; Malizia A. (1999). Measurement of brain GABA-benzodiazepine receptor levels in vivo using emission tomography. Methods Mol Biol. 106:119-136.
• Lingford-Hughes A; Nutt D. (1 May 2000). Alcohol and drug abuse. CURRENT OPINION IN PSYCHIATRY. 13:291-298. DOI.
• Lingford-Hughes AR; Cunningham VJ; Feeney AJ; Wilson SJ; Gunn RN; Stephenson B; Brooks DJ; Nutt DJ. (1 May 2000). The function of the GABA-benzodiazepine receptor in alcohol dependence. JOURNAL OF NUCLEAR MEDICINE. 41:136P-136P. Author weblink.
• Daglish MR; Melichar JK; Lingford-Hughes AR; Brooks DJ; Myles JS; Nutt DJ. (1 May 2000). C-11-diprenorphine PET imaging of opioid binding during chronic methadone treatment and early abstinence. JOURNAL OF NUCLEAR MEDICINE. 41:106P-106P.
• Daglish M; Lingford-Hughes A; Stevenson B; Feeney A; Myles J; Grasby P; Nutt D. (1 Jun 2001). Mapping neural activation to alcohol cues in abstinent alcoholics - variability of behavioural and rCBF responses in the scanner environment. NEUROIMAGE. 13:S1039-S1039. Author weblink.
• Daglish MRC; Lingford-Hughes A; Williams T; Wilson S; Brooks DJ; Myles JS; Grasby P; Nutt DJ. (1 Mar 2002). A PET study testing the dopamine hypothesis in opiate dependence in humans. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S22-S23. Author weblink.
• Daglish MRC; Lingford-Hughes A; Williams TM; Davies SJC; Melichar JK; Brooks DJ; Myles JS; Nutt DJ. (1 Mar 2002). A PET study of brain opioid receptor changes after withdrawal from chronic methadone treatment. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S22-S22. Author weblink.
• Lingford-Hughes A; Daglish MRC; Wilson S; Weinstein A; Malizia AL; Melichar JK; Stevenson BJ; Feeney A; et alPandit SA; Myles JS; Grasby PJ; Nutt DJ. (1 Mar 2002). Blood flow changes in abstinent addicts during cue exposure and craving for their drug of choice. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S21-S22. Author weblink.
• Wilson S; Lingford-Hughes A; Cunningham VJ; Gunn R; Feeney A; Stevenson BJ; Myles J; Brooks DJ; et alNutt DJ. (1 Mar 2002). Assessing the function of the GABA-benzodiazepine receptor in alcohol dependence using PET and EEG. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S21-S21. Author weblink.
• Melichar JK; Taylor LG; Daglish MRC; Holmes RB; Parkin VJ; Rees MR; Lenox-Smith A; Lingford-Hughes AR; et alNutt DJ. (1 Mar 2002). A single photon emission tomography (SPET) study of noradrenergic function in generalised anxiety disorder (GAD). EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S20-S21. Author weblink.
• Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; et alNutt DJ. (1 Mar 2002). Imaging in vivo the GABA-benzodiazepine receptor containing the alpha 5 subunit in man and rat. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S20-S20. Author weblink.
• Daglish M; Lingford-Hughes A; Williams T; Wilson S; Brooks D; Myles J; Grasby P; Nutt D. (1 Jul 2002). Does opioid induced dopamine release in humans require a subjective "high"? A pet study with 11C-raclopride. NEUROIMAGE. 16:S95-S95. Author weblink.
• Lingford-Hughes A; Hume S; Feeney A; Hirani E; Osman S; Cunningham V; Pike V; Brooks D; et alNutt D. (1 Jul 2002). [11C]Ro15 4513 PET predominantly labels the alpha 5-containing GABA-benzodiazepine receptor in vivo. NEUROIMAGE. 16:S27-S27. Author weblink.
• Daglish MRC; Lingford-Hughes A; Williams TM; Wilsona SJ; Brooksc DJ; Myles JS; Grasby P; Nutt DJ. (1 Sep 2002). A human pet study of dopamine response to hydromorphone. BEHAVIOURAL PHARMACOLOGY. 13:479-480. Author weblink.
• Hickman M; Lingford-Hughes A; Bailey C; Macleod J; Nutt D; Henderson G. (1 Jul 2008). Understanding causal pathways: A response to the commentaries. ADDICTION. 103:1067-1068. DOI.
• Zammit S; Moore THM; Lingford-Hughes A; Barnes TRE; Jones PB; Burke M; Lewis G. (1 Nov 2008). Effects of cannabis use on outcomes of psychotic disorders: systematic review. BRITISH JOURNAL OF PSYCHIATRY. 193:357-363. Author weblink DOI.
• Watson BJ; Wilson S; Griffin L; Kalk NJ; Taylor LG; Munafo MR; Lingford-Hughes AR; Nutt DJ. (1 Jul 2011). A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. PSYCHOPHARMACOLOGY. 216:121-129. Author weblink DOI.
• Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Britten S; Brewer C; Lingford-Hughes A; et alMyles JS; Grasby P; Nutt DJ. (1 Oct 2001). Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. AMERICAN JOURNAL OF PSYCHIATRY. 158:1680-1686. Author weblink DOI.
• Lingford-Hughes A; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; et alNutt DJ. (Jul 2002). Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography. J Cereb Blood Flow Metab. 22:878-889. DOI.
• Lingford-Hughes A; Nutt D. (Feb 2003). Neurobiology of addiction and implications for treatment. Br J Psychiatry. 182:97-100.
• Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ. (2003). Addiction. Br Med Bull. 65:209-222.
• Nutt D; Lingford-Hughes A; Daglish M. (2003). Future directions in substance dependence research. J Neural Transm Suppl. 95-103.
• Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D. (Jun 2003). A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients. Addict Biol. 8:229-232. DOI.
• Daglish MR; Weinstein A; Malizia AL; Wilson S; Melichar JK; Lingford-Hughes A; Myles JS; Grasby P; et alNutt DJ. (Dec 2003). Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"?. Neuroimage. 20:1964-1970.
• Nutt D; Lingford-Hughes A. (3 Aug 2004). Infecting the brain to stop addiction?. Proc Natl Acad Sci U S A. 101:11193-11194. DOI.
• Melichar JK; Hume SP; Williams TM; Daglish MRC; Taylor LG; Ahmad R; Malizia AL; Brooks DJ; et alMyles JS; Lingford-Hughes A; Nutt DJ. (1 Jan 2005). Using [C-11]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 312:309-315. Author weblink DOI.
• Lingford-Hughes AR; Welch S; Nutt DJ; British Association for Psychopharmacology. (Sep 2004). Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 18:293-335. DOI.
• Lingford-Hughes AR; Wilson SJ; Cunningham VJ; Feeney A; Stevenson B; Brooks DJ; Nutt DJ. (Aug 2005). GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study. Psychopharmacology (Berl). 180:595-606. DOI.
• Daglish M; Lingford-Hughes A; Nutt D. (2005). Human functional neuroimaging connectivity research in dependence. Rev Neurosci. 16:151-157.
• Lingford-Hughes A; Wilson SJ; Feeney A; Grasby PG; Nutt DJ. (1 Aug 2005). A proof-of-concept study using [C-11]flumazenil PET to demonstrate that pagoclone is a partial agonist. PSYCHOPHARMACOLOGY. 180:789-791. DOI.
• Davies SJ; Pandit SA; Feeney A; Stevenson BJ; Kerwin RW; Nutt DJ; Marshall EJ; Boddington S; et alLingford-Hughes A. (Nov 2005). Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?. Alcohol Alcohol. 40:498-503. DOI.
• Lingford-Hughes AR; Daglish MRC; Stevenson BJ; Feeney A; Pandit SA; Wilson SJ; Myles J; Grasby PM; et alNutt DJ. (1 Mar 2006). Imaging alcohol cue exposure in alcohol dependence using a PET O-15-H2O paradigm: results from a pilot study. ADDICTION BIOLOGY. 11:107-115. Author weblink DOI.
• Hammers A; Lingford-Hughes A. (Nov 2006). Opioid imaging. Neuroimaging Clin N Am. 16:529-vii. DOI.
• Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ. (Aug 2007). Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates. J Pharmacol Exp Ther. 322:661-667. DOI.
• Montgomery AJ; Lingford-Hughes AR; Egerton A; Nutt DJ; Grasby PM. (Aug 2007). The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study. Synapse. 61:637-645. DOI.
• Bailey JE; Papadopoulos A; Lingford-Hughes A; Nutt DJ. (Sep 2007). D-Cycloserine and performance under different states of anxiety in healthy volunteers. Psychopharmacology (Berl). 193:579-585. DOI.
• Williams TM; Daglish MRC; Lingford-Hughes A; Taylor LG; Hammers A; Brooks DJ; Grasby P; Myles JS; et alNutt DJ. (1 Jul 2007). Brain opioid receptor binding in early abstinence from opioid dependence - Positron emission tomography study. BRITISH JOURNAL OF PSYCHIATRY. 191:63-69. Author weblink DOI.
• Moore TH; Zammit S; Lingford-Hughes A; Barnes TR; Jones PB; Burke M; Lewis G. (28 Jul 2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 370:319-328. DOI.
• Nutt DJ; Besson M; Wilson SJ; Dawson GR; Lingford-Hughes AR. (Dec 2007). Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology. 53:810-820. DOI.
• Hitsman B; MacKillop J; Lingford-Hughes A; Williams TM; Ahmad F; Adams S; Nutt DJ; Munafò MR. (Mar 2008). Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology (Berl). 196:611-621. DOI.
• Reid AG; Daglish MRC; Kempton MJ; Williams TM; Watson B; Nutt DJ; Lingford-Hughes AR. (1 Jan 2008). Reduced thalamic grey matter volume in opioid dependence is influenced by degree of alcohol use: a voxel-based morphometry study. JOURNAL OF PSYCHOPHARMACOLOGY. 22:7-10. Author weblink DOI.
• Hickman M; Lingford-Hughes A; Bailey C; Macleod J; Nutt D; Henderson G. (Jul 2008). Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction. 103:1060-1062. DOI.
• Nutt D; Lingford-Hughes A. (May 2008). Addiction: the clinical interface. Br J Pharmacol. 154:397-405. DOI.
• Taylor C; Nash J; Rich A; Lingford-Hughes A; Nutt D; Potokar J. (Nov 2008). Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence. Alcohol Alcohol. 43:614-618. DOI.
• Daglish MR; Williams TM; Wilson SJ; Taylor LG; Eap CB; Augsburger M; Giroud C; Brooks DJ; et alMyles JS; Grasby P; Lingford-Hughes AR; Nutt DJ. (Jul 2008). Brain dopamine response in human opioid addiction. Br J Psychiatry. 193:65-72. DOI.
• Williams TM; Davies SJC; Taylor LG; Daglish MRC; Hammers A; Brooks DJ; Nutt DJ; Lingford-Hughes A. (1 Oct 2009). Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [C-11]diprenorphine PET study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 19:740-748. Author weblink DOI.
• Hood SD; Melichar JK; Taylor LG; Kalk N; Edwards TR; Hince DA; Lenox-Smith A; Lingford-Hughes AR; et alNutt DJ. (Jan 2011). Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. J Psychopharmacol. 25:78-86. DOI.
• Stokes PR; Egerton A; Watson B; Reid A; Breen G; Lingford-Hughes A; Nutt DJ; Mehta MA. (1 Oct 2010). Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage. 52:1521-1527. DOI.
• Kalk NJ; Nutt DJ; Lingford-Hughes AR. (Jan 2011). The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies. J Psychopharmacol. 25:3-16. DOI.
• Colasanti A; Rabiner EA; Lingford-Hughes A; Nutt DJ. (Nov 2011). Opioids and anxiety. J Psychopharmacol. 25:1415-1433. DOI.
• Tyacke RJ; Lingford-Hughes A; Reed LJ; Nutt DJ. (2010). GABAB receptors in addiction and its treatment. Adv Pharmacol. 58:373-396. DOI.
• Lingford-Hughes A; Reid AG; Myers J; Feeney A; Hammers A; Taylor LG; Rosso L; Turkheimer F; et alBrooks DJ; Grasby P; Nutt DJ. (Feb 2012). A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions. J Psychopharmacol. 26:273-281. DOI.
• Stokes PR; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR. (Jan 2012). History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol. 26:144-149. DOI.
• Kalk NJ; Melichar J; Holmes R; Taylor L; Daglish M; Hood S; Edwards T; Lennox-Smith A; et alLingford-Hughes A; Nutt DJ. (Apr 2012). Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study. J Psychopharmacol. 26:452-460. DOI.
• Lingford-Hughes AR; Nutt DJ. (2003). The neurobiology of addiction and implications for treatment. British Journal of Psychiatry. 182:97-100.
• Nutt DJ; Lingford-Hughes AR. (2004). Infecting the brain to stop addiction?. Proceedings of the National Academy of Sciences of USA. 101:11193-11194.
• Lingford-Hughes AR. (2005). Human brain imaging and substance abuse. Current Opinion in Pharmacology. 5:42-46.
• Hammers A; Lingford-Hughes A. (2006). Opioid imaging. NEUROIMAGING CLINICS OF NORTH AMERICA. 16:529-552.
• Lingford-Hughes AR; Watson BJ. (2007). Pharmacological treatment of addiction. Psychiatry. 6:309-312.
• Clementi N; Lingford-Hughes A. (2008). Addictions and substance misuse. Medicine. 36:422-429.
• Nutt DJ; Lingford-Hughes AR. (2008). Addiction: the clinical interface. British Journal of Pharmacology. 154:397-405.
• Tyacke RJ; Lingford-Hughes AR; Reed LJ; Nutt DJ. (2010). GABAB Receptors in Addiction and Its Treatment. Advances in Pharmacology. 58:373-396.
• Lingford-Hughes AR; Watson BJ; Kalk NJ; Reid A. (2010). Neuropharmacology of addiction and how it informs treatment. British Medical Bulletin. 96:93-110.
• Immadisetty V; Cant T; Thyarappa P; Lingford-Hughes A; Vernon J. (2009). Biomarkers for detecting thiamine deficiency – improving confidence and taking a comprehensive history are also important. Alcohol and Alcoholism. 44:634.
• Lingford-Hughes AR; Acton PD; Gacinovic S; Boddington SJA; Costa DC; Pilowsky LS; Ell PJ; Marshall EJ; et alKerwin RW. (2000). Levels of GABA-benzodiazepine receptors in female abstinent alcohol dependent subjects : preliminary findings from an [123I]-iomazenil single photon emission tomography study. Alcoholism-Clinical and Experimental Research. 24:1449-1455.
• Lingford-Hughes AR; Hume SP; Feeney A; Hirani E; Osman S; Cunningham VJ; Pike VW; Brooks DJ; et alNutt DJ. (2002). Imaging the GABA-benzodiazepine receptor subtype containing the a5-subunit in vivo with PET. Journal of Pharmacology and Experimental Therapeutics. 22:878-889.
• Munafo MR; Lingford-Hughes AR; Johnstone EC; Walton RT. (2005). Association Between the Serotonin Transporter Gene and Alcohol Consumption in Social Drinkers. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 135B:10-15.
• Zetteler J; Stollery BT; Weinstein AM; Lingford-Hughes AR. (2006). Attentional bias for alcohol-related information in adolescents with alcohol-dependent parents. Alcohol and Alcoholism. 41:426-430.
• Williams TM; Daglish MRC; Lingford-Hughes AR; Taylor LG; Hammers A; Brooks DJ; Grasby PG; Myles JS; et alNutt DJ. (2007). Increased availability of opioid receptors in early abstinence from opioid dependence: a [11C]diprenorphine PET study. British Journal of Psychiatry. 191:63-69.
• Wiles NJ; Lingford-Hughes AR; Daniel J; Hickman M; Farrell M; Macleod J; Haynes J; Skapinakis P; et alAraya R; Lewis G. (2007). Socio-economic status in childhood and later alcohol use: a systematic review. Addiction. 102:1546-1563.
• Daniels JZ; Hickman M; Macleod J; Wiles N; Lingford-Hughes AR; Farrell M; Araya R; Skapinakis P; et alHaynes J; Lewis G. (2009). Is socio-economic status in early life associated with drug use? A systematic review of the evidence. Drug and Alcohol Review. 28:142-153.
• Goodwin GM; Consensus Group. (2009). Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 23:346-388.
• Barnes TR; Schizophrenia Consensus Group. (2011). Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 25:567-620.
• Kalk NJ; Melichar J; Holmes RB; Taylor LG; Daglish MRC; Hood S; Edwards T; Lennox-Smith A; et alLingford-Hughes AR; Nutt DJ. (2011). Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography Study. Journal of Psychopharmacology.
• Myers JFM; Rosso L; Watson BJ; Wilson SJ; Kalk NJ; Clementi N; Brooks DJ; Nutt DJ; et alTurkheimer FE; Lingford-Hughes AR. (2011). Characterization of the contribution of the GABA-benzodiazepine α1 receptor subtype to [11C]Ro15-4513 PET images. Journal of Cerebral Blood Flow and Metabolism.

Conferences

• Watson BJ; Taylor LG; Reid A; Wilson SJ; Stokes PR; Brooks DJ; Bose SK; Turkheimer F; et alLingford-Hughes AR; Nutt DJ. Investigating the effect of expectation on striatal dopamine release in heroin addicts: an C-11-raclopride PET study. 24th Congress of the European-College-of-Neuropsychopharmacology, 3 Sep 2011 - 7 Sep 2011. 21:S320-S320. ELSEVIER SCIENCE BV (1 Sep 2011). Author weblink.
• Lingford-Hughes A; Myers J; Wilson S; Stokes P; Taylor L; Watson B; Kalk N; Besson M; et alFeeney A; Rosso L; Turkheimer F; Cunningham VJ; Pike VW; Brooks DJ; Marshall EJ; Kerwin RW; Nutt DJ. THE GABA-BENZODIAZEPINE RECEPTOR, ITS SUBTYPES AND ALCOHOL MISUSE: INSIGHTS FROM IMAGING AND PHARMACOLOGICAL CHALLENGE STUDIES. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A79-A79. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
• Benecke A; Shotbolt JP; Egerton A; Nutt D; Lingford-Hughes AR; Howes O; Stokes PRA. DOES PRESYNAPTIC STRIATAL DOPAMINE SYNTHESIS CAPACITY PREDICT SOCIALLY DESIRABLE RESPONDING?. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A42-A42. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
• Stokes PR; Clark L; Wu K; Michalczuk R; Watson B; Egerton A; Lappin J; Piccini P; et alNutt D; Bowden-Jones H; Lingford-Hughes A. IMAGING THE DOPAMINE SYSTEM IN PATHOLOGICAL GAMBLING: AN [11C]-RACLOPRIDE PET STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A61-A61. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
• Lingford-Hughes A. Neuroimaging studies of GABA(A) receptors and alcoholism. 10th Biennial Meeting of the European-Behavioural-Pharmacology-Society, 6 Sep 2003 - 9 Sep 2003. 14:S6-S6. LIPPINCOTT WILLIAMS & WILKINS (1 Sep 2003). Author weblink.
• Lingford-Hughes A. Imaging GABA(A) receptor subtypes with PET. 12th International Congress of the International-Society-for-Biomedical-Research-on-Alcoholism, 29 Sep 2004 - 2 Oct 2004. 28:75A-75A. LIPPINCOTT WILLIAMS & WILKINS (1 Aug 2004). Author weblink DOI.
• Lingford-Hughes A. Imaging benzodiazepine subtypes and receptor function. Annual Meeting of the American-College-of-Neuropsychopharmacology, 12 Dec 2004 - 16 Dec 2004. 29:S43-S43. NATURE PUBLISHING GROUP (1 Dec 2004). Author weblink.
• Lingford-Hughes AR. Treatment of alcohol dependence (BAP guidelines). 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S362-S362. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
• Lingford-Hughes A. Using 11C-Ro15 4513, a benzodiazepine inverse agonist, as a PET tracer to study the alpha-5 subtype GABA-BDZ in alcoholism. Conference on Alcoholism and Stress - A Framework for Future Treatment Strategies, 6 May 2008 - 8 May 2008. 42:313-313. ELSEVIER SCIENCE INC (1 Jun 2008). Author weblink.
• Lees R; Williams T; Henderson G; Hickman M; Lingford-Hughes A. Interaction between alcohol and opioids in opioid-dependent subjects. ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe, 4 Mar 2010 - 7 Mar 2010. 20:S73-S74. ELSEVIER SCIENCE BV (1 Mar 2010). Author weblink.
• Lees R; Williams T; Barford-Turner S; Pickering A; Kendrick A; Waygood C; Hickman M; Henderson G; et alLingford-Hughes A. RESPIRATORY CHANGES FOLLOWING ALCOHOL ADMINISTRATION IN OPIOID-DEPENDENT HUMAN PARTICIPANTS. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A30-A30. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
• Williams TM; Lees R; Lovell RM; Henderson G; Nutt DJ; Lingford-Hughes A. Respiratory changes following benzodiazepine administration in opioid-dependent human participants. 23rd Congress Meeting of European-College-of-Neuropsychopharmacology, 28 Aug 2010 - 1 Sep 2010. 20:S585-S586. ELSEVIER SCIENCE BV (1 Aug 2010). Author weblink.
• Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Lingford-Hughes A; Myles JS; Grasby P; et alNutt DJ. Functional connectivity analysis of rCBF in opiate craving. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A55-A55. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
• Williams TM; Daglish MRC; Lingford-Hughes A; Hammers A; Brooks DJ; Myles JS; Nutt DJ. Altered brain opioid receptor density after withdrawal from methadone treatment. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A54-A54. SAGE PUBLICATIONS LTD (1 Sep 2002). Author weblink.
• Melichar JK; Taylor LG; Daglish MRC; Holmes RB; Parkin VJ; Rees MR; Lenox-Smith A; Lingford-Hughes AR; et alNutt DJ. Noradrenergic dysfunction in generalised anxiety disorder (GAD): A SPET study using a clonidine challenge. Summer Meeting of the British-Association-for-Psychopharmacology, 21 Jul 2002 - 24 Jul 2002. 16:A52-A52. SAGE PUBLICATIONS LTD (1 Sep 2002).
• Williams TM; Daglish MRC; Lingford-Hughes A; Hammers A; Brooks DJ; Myles JS; Nutt DJ. Regional cerebral increases in opioid receptor density in early abstinence from methadone: a PET study in man. 4th ECNP Workshop 2003. 13:S31-S31. (Mar 2003).
• Melichar JK; Witchel HJ; Taylor LG; Lingford-Hughes AR; Nutt DJ. Heart rate variability (HRV) and noradrenergic dysfunction in generalised anxiety disorder (GAD): Assessment using a clonidine challenge. Summer Meeting of the British-Association-for-Psychopharmacology, 20 Jul 2003 - 23 Jul 2003. 17:A29-A29. SAGE PUBLICATIONS LTD (1 Sep 2003).
• Daglish MRC; Lingford-Hughes AR; Nutt DJ. Brain imaging alcohol cue-reactivity. 12th International Congress of the International-Society-for-Biomedical-Research-on-Alcoholism, 29 Sep 2004 - 2 Oct 2004. 28:65A-65A. LIPPINCOTT WILLIAMS & WILKINS (1 Aug 2004). Author weblink DOI.
• Lingford-Hughes AR; Hayward RC; Mill J; Ball D; Nutt DJ. Dopamine receptor genotypes in non-dependent and dependent smokers. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2004 - 28 Jul 2004. 18:A30-A30. SAGE PUBLICATIONS LTD (1 Sep 2004).
• Wilson SJ; Besson M; Lingford-Hughes A; Dawson GR; Nutt DJ. Antagonisinc alcohol's actions by an inverse agonist at alpha 5 subtype GABA(A) receptors in humans. Summer Meeting of the British-Association-for-Psychoparmacology, 24 Jul 2005 - 27 Jul 2005. 19:A24-A24. SAGE PUBLICATIONS LTD (1 Sep 2005). Author weblink.
• Welch S; Lingford-Hughes AR; Nutt DJ. Treatment of nicotine dependence and cocaine addiction. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S361-S362. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
• Daglish M; Lingford-Hughes AR; Grasby PG; Brooks DJ; Nutt DJ. Does heroin release dopamine? A positron emission tomography study. 18th ECNP Congress 2005, 22 Oct 2005 - 26 Oct 2005. 15:S341-S341. ELSEVIER SCIENCE BV (1 Oct 2005). Author weblink.
• Lingford-Hughes AR; Daglish M; Brooks DJ; Nutt DJ. Imaging brain opioid receptors in alcohol and heroin dependence. 18th ECNP Congress 2005. 15:S331-S331. (Oct 2005).
• Williams TM; Lingford-Hughes A; Daglish MRC; Taylor LG; Hammers A; Brooks DJ; Grasby P; Nutt DJ. Increased opiold receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving. ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe. 17:S78-S79. (Mar 2007).
• Williams TM; Lingford-Hughes A; Davies SJC; Daglish MRC; Taylor LG; Hammers A; Brooks DJ; Grasby P; et alMyles JS; Nutt DJ. Increased opioid receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving. 20th Congress of the European-College-of-Neuropsychopharmacology. 17:S187-S188. (Oct 2007).
• Hood S; Melichar J; Taylor L; Daglish M; Holmes RB; Parkin VJ; Rees M; Kalk N; et alLenox-Smith A; Lingford-Hughes A; Nutt D. Noradrenergic function in generalised anxiety disorder (GAD): A single photon emission tomography (SPET) study. 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), 13 Jul 2008 - 17 Jul 2008. 11:278-278. CAMBRIDGE UNIV PRESS (1 Jul 2008).
• Williams TM; Davies SJC; Taylor LG; Daglish MR; Nutt DJ; Lingford-Hughes A. Can personality traits elucidate the relationship between substance dependence and opioid receptor availability?. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S536-S536. ELSEVIER SCIENCE BV (1 Aug 2008). DOI.
• Williams TM; Davies SJC; Taylor LG; Nutt DJ; Lingford-Hughes A. Association between opioid receptor availability and anxiety in healthy controls but not in substance dependence. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S653-S654. ELSEVIER SCIENCE BV (1 Sep 2009).
• Tyacke RJ; Robinson ESJ; Harris A; Lingford-Hughes AR; Nutt DJ. Paradoxical effects of GABA on the in vivo uptake of the partial inverse GABA agonist [3H]Ro15-4513 in rat brain. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S276-S277. ELSEVIER SCIENCE BV (1 Sep 2009).
• Myers JFM; Rosso L; Kalk NJ; Watson BJ; Wilson S; Brooks DJ; Nutt DJ; Turkheimer FE; et alLingford-Hughes AR. The effects of zolpidem on in vivo binding of [C11]-flumazenil and [C11]-Ro15-4513. 8th International Symposium on Functional Neuroreceptor Mapping of the Living Brain, 22 Jul 2010 - 24 Jul 2010. 52:S191-S192. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Aug 2010). DOI.
• Stokes PRA; Shotbolt JP; Copeland C; Nutt D; Lingford-Hughes AR; Howes O. PREVIOUS COCAINE USE DECREASES PRESYNAPTIC LIMBIC DOPAMINERGIC FUNCTION: A [18F]-DOPA PET STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A57-A57. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
• Lingford-Hughes AR; Watson B; Daglish MR; Reid A; Williams TM; Wilson SJ; Taylor LG; Stokes P; et alNutt DJ. IMAGING THE ROLE OF DOPAMINE IN HUMAN OPIOID ADDICTS. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A8-A8. SAGE PUBLICATIONS LTD (1 Aug 2010). Author weblink.
• Erritzoe D; Tziortzi A; Bargiela D; Searle G; Gunn RN; Beaver JD; Waldman A; Nutt D; et alBani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A. In Vivo Imaging of Dopamine D3 Receptors in Alcoholism Using Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist. 66th Annual Meeting of the Society-of-Biological-Psychiatry, 12 May 2011 - 14 May 2011. 69:271S-271S. ELSEVIER SCIENCE INC (1 May 2011). Author weblink.
• Watson BJ; Bowsher B; Wilson S; Taylor LG; Kalk NJ; Griffin L; Lingford-Hughes AR; Munafo M; et alNutt DJ. A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol dependent subjects. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S640-S640. ELSEVIER SCIENCE BV (1 Sep 2009).